收稿日期: 2021-10-09
网络出版日期: 2024-12-18
版权
Impact of type 2 diabetes mellitus on the prognosis of patients with oral squamous cell carcinoma
Received date: 2021-10-09
Online published: 2024-12-18
Copyright
目的: 分析合并2型糖尿病(diabetes mellitus, DM)对罹患口腔鳞状细胞癌(oral squamous cell carcinoma, OSCC)的患者预后的影响。方法: 回顾性分析2014年1月至2017年12月间北京大学口腔医院口腔颌面外科收治的309例OSCC患者的临床病理资料,其中DM组104例,无DM组205例,对患者的基本临床资料和预后情况进行总结分析,利用倾向评分匹配(propensity score matching, PSM)方法均衡两组的组间协变量,采用Kaplan-Meier方法计算两组患者的生存率,采用Cox回归分析影响预后的风险因素,并分析DM组血糖控制情况对生存结果的影响。结果: 经过PSM,两组共有77对匹配成功,组间协变量达到均衡。两组患者术后出现黏膜癌前病变以及局部复发的比例差异有统计学意义(P < 0.05)。两组患者的生存分析结果差异无统计学意义,但经过匹配后,DM组的生存率有低于无DM组的趋势。单因素及多因素分析显示,肿瘤分期是OSCC患者总生存率及肿瘤特异性生存率的独立影响因素(P < 0.05),而有无DM对OSCC患者的生存影响差异无统计学意义(P>0.05)。针对DM组的多因素分析发现,肿瘤分期、甘油三酯水平、术前平均末梢血糖(空腹)、术后平均末梢血糖(餐后2 h)是DM组患者术后总生存情况的独立危险因素;肿瘤分期和术后平均末梢血糖(餐后2 h)是DM组患者术后肿瘤特异性生存率的独立危险因素。DM组内的血糖控制欠佳组出现术后并发症及远处转移的风险有高于血糖控制良好组的趋势。结论: 有无DM对患者的总生存率及肿瘤特异性生存率的影响差异无统计学意义,但DM组术后出现黏膜癌前病变或局部肿瘤复发的可能性高于无DM组;糖尿病患者的肿瘤分期、甘油三酯水平、血糖控制情况可能影响其预后。
毛雅晴 , 陈震 , 于尧 , 章文博 , 刘洋 , 彭歆 . 2型糖尿病对口腔鳞状细胞癌患者预后的影响[J]. 北京大学学报(医学版), 2024 , 56(6) : 1089 -1096 . DOI: 10.19723/j.issn.1671-167X.2024.06.023
Objective: To analyze the influence of type 2 diabetes mellitus (DM) on the prognosis of oral squamous cell carcinoma (OSCC) patients with surgical treatment. Methods: The clinical data of 309 patients, who were diagnosed with OSCC and admitted to the same ward of Peking University Hospital of Stomatology from January 2014 to December 2017 were retrospectively reviewed, of whom, 104 were classified into DM group and 205 into non-DM group. The basic clinical data and follow-up results of the patients were analyzed and compared. Propensity score matching (PSM) was used to reduce confounding bias between the DM group and the non-DM group. Kaplan-Meier was used to calculate the survival rate of the two groups. Proportional hazards model was used to analyze the independent prognostic factors. The effect of glucose level on survival was analyzed. Results: After PSM, 77 patients in each group were matched and the variables were balanced. There were statistically significant differences in postoperative oral dysplasia and local recurrence between the two groups (P < 0.05). There was no significant difference in survival analysis between the two groups, but the survival rate of the DM group had the tendency to be lower than that of the non-DM group after matching. Univariate analysis and multiva-riate analysis both revealed that the tumor stage was an independent factor influencing the overall survival rate and tumor-specific survival rate of the OSCC patients (P < 0.05), while diabetes had no significant influence on the survival of the OSCC patients (P>0.05). Multivariate analysis showed that tumor stage, triglyceride level, preoperative mean capillary fasting blood glucose, postoperative mean postprandial blood glucose were indepen-dent prognostic factors for overall survival in the DM group. Tumor stage and mean postoperative postprandial blood glucose were independent prognostic factors for tumor-specific survival in the DM group. The risk of postoperative complications and distant metastasis in the DM group with poor glycemic control was higher than that in the good glycemic controls. Conclusion: There is no significant difference in overall survival and tumor-specific survival of the patients with or without DM. However, the possibility of mucosal dysplasia or local recurrence in the DM group is higher than that in the non-DM group. The tumor stage, triglyceride level and glycemic control of the patients with DM may affect their prognosis.
| 1 | Campbell PT , Newton CC , Patel AV , et al.Diabetes and cause-specific mortality in a prospective cohort of one million U.S. adults[J].Diabetes Care,2012,35(9):1835-1844. |
| 2 | 赵佳, 韩雪, 谢梦, 等.2型糖尿病并发恶性肿瘤患者的流行病学分析[J].中国慢性病预防与控制,2018,26(7):514-516. |
| 3 | Tsilidis KK , Kasimis JC , Lopez DS , et al.Type 2 diabetes and cancer: Umbrella review of meta-analyses of observational studies[J].BMJ,2015,350,g7607. |
| 4 | Vairaktaris E , Spyridonidou S , Goutzanis L , et al.Diabetes and oral oncogenesis[J].Anticancer Res,2007,27(6B):4185-4193. |
| 5 | Wu CH , Wu TY , Li CC , et al.Impact of diabetes mellitus on the prognosis of patients with oral squamous cell carcinoma: A retrospective cohort study[J].Ann Surg Oncol,2010,17(8):2175-2183. |
| 6 | Stott-Miller M , Chen C , Schwartz SM .Type Ⅱ diabetes and metabolic syndrome in relation to head and neck squamous cell carcinoma risk: A SEER-Medicare database study[J].Cancer Epidemiol,2013,37(4):428-433. |
| 7 | Tseng CH .Oral cancer in Taiwan: Is diabetes a risk factor?[J].Clin Oral Investig,2013,17(5):1357-1364. |
| 8 | 中华医学会糖尿病学分会.中国2型糖尿病防治指南(2020年版)[J].中华内分泌代谢杂志,2021,37(4):311-398. |
| 9 | Pfister DG , Spencer S , Adelstein D , et al.Head and neck cancers, version 2.2020, NCCN clinical practice guidelines in oncology[J].J Natl Compr Canc Netw,2020,18(7):873-898. |
| 10 | Amin MB , Edge SB , Greene FL , et al.AJCC cancer staging manual[M].8th ed. New York: Springer,2017. |
| 11 | 高柳, 毛驰, 俞光岩, 等.成人并存疾病评价指数27条目中文简体版引进的授权、翻译回译和语义调适[J].中华口腔医学杂志,2016,51(10):623-627. |
| 12 | Austin PC .An introduction to propensity score methods for reducing the effects of confounding in observational studies[J].Multivariate Behav Res,2011,46(3):399-424. |
| 13 | Ling S , Brown K , Miksza JK , et al.Risk of cancer incidence and mortality associated with diabetes: A systematic review with trend analysis of 203 cohorts[J].Nutr Metab Cardiovasc Dis,2020,31(1):14-22. |
| 14 | Pearson-Stuttard J , Bennett J , Cheng YJ , et al.Trends in predominant causes of death in individuals with and without diabetes in England from 2001 to 2018: An epidemiological analysis of linked primary care records[J].Lancet Diabetes Endocrinol,2021,9(3):165-173. |
| 15 | 周维, 何明艳, 沈婉莹, 等.2005—2015年中国口腔癌发病及死亡趋势分析[J].华中科技大学学报(医学版),2020,49(6):58-63. |
| 16 | Végh D , Bányai D , Ujpál M .Change in the incidence of diabetes mellitus in oral cancer patients based on a long-term comparative study[J].Fogorv Sz,2015,108(1):9-12. |
| 17 | Yan P , Wang Y , Yu X , et al.Type 2 diabetes mellitus and risk of head and neck cancer subtypes: A systematic review and meta-analysis of observational studies[J].Acta Diabetol,2021,58(5):549-565. |
| 18 | 王新革. 舌鳞癌与肿瘤侵袭模式、2型糖尿病的相关性研究[D]. 西安: 第四军医大学, 2017: 42. |
| 19 | Supabphol S , Seubwai W , Wongkham S , et al.High glucose: An emerging association between diabetes mellitus and cancer progression[J].J Mol Med (Berl),2021,99(9):1175-1193. |
| 20 | Cignarelli A , Annamaria Genchi V , Caruso I , et al.Diabetes and cancer: Pathophysiological fundamentals of a "dangerous affair"[J].Diabetes Res Clin Pract,2018,143,378-388. |
| 21 | Liu CJ , Chang WJ , Chen CY , et al.Dynamic cellular and mole-cular modulations of diabetes mediated head and neck carcinogenesis[J].Oncotarget,2015,30(6):29268-29284. |
| 22 | 张东升, 郑家伟, 张陈平, 等.口腔癌合并全身系统性疾病患者的多学科协作诊疗模式专家共识[J].华西口腔医学杂志,2020,38(6):603-615. |
| 23 | 李金, 华红. 口腔癌中国流行病学趋势及口腔白斑癌变危险因素分析[D]. 北京: 北京大学, 2019. |
| 24 | Villa A , Woo SB .Leukoplakia: A diagnostic and management algorithm[J].J Oral Maxillofac Surg,2017,75(4):723-734. |
| 25 | Li G , Da M , Zhang W , et al.Alteration of serum lipid profile and its prognostic value in head and neck squamous cell carcinoma[J].J Oral Pathol Med,2016,45(3):167-172. |
| 26 | Shalapour S , Karin M .Immunity, inflammation, and cancer: An eternal fight between good and evil[J].J Clin Invest,2015,125(9):3347-3355. |
| 27 | Lu A , Li H , Zheng Y , et al.Prognostic significance of neutrophil to lymphocyte ratio, lymphocyte to monocyte ratio, and platelet to lymphocyte ratio in patients with nasopharyngeal carcinoma[J].Biomed Res Int,2017,2017,3047802. |
/
| 〈 |
|
〉 |